Ashton Thomas Private Wealth’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $37.5M | Buy |
103,640
+3,434
| +3% | +$1.18M | 0.78% | 19 |
|
|
2026
Q1 | $35.3M | Buy |
100,206
+4,375
| +5% | +$1.56M | 0.83% | 21 |
|
|
2025
Q4 | $31.4M | Buy |
95,831
+1,041
| +1% | +$330K | 0.76% | 23 |
|
|
2025
Q3 | $26.7M | Buy |
94,790
+2,667
| +3% | +$773K | 0.69% | 25 |
|
|
2025
Q2 | $25.7M | Buy |
92,123
+3,633
| +4% | +$1.03M | 0.91% | 17 |
|
|
2025
Q1 | $27.6M | Buy |
88,490
+1,195
| +1% | +$353K | 1.05% | 12 |
|
|
2024
Q4 | $22.8M | Buy |
87,295
+4,087
| +5% | +$1.21M | 0.88% | 16 |
|
|
2024
Q3 | $26.8M | Buy |
83,208
+2
| +0% | +$654 | 1.41% | 8 |
|
|
2024
Q2 | $26M | Buy |
83,206
+2,065
| +3% | +$607K | 1.42% | 5 |
|
|
2024
Q1 | $23.1M | Buy |
81,141
+15,450
| +24% | +$4.52M | 1.32% | 10 |
|
|
2023
Q4 | $18.9M | Buy |
65,691
+196
| +0.3% | +$53.4K | 1.19% | 10 |
|
|
2023
Q3 | $17.6M | Buy |
65,495
+688
| +1% | +$172K | 1.28% | 11 |
|
|
2023
Q2 | $14.4M | Buy |
64,807
+6,472
| +11% | +$1.5M | 1.1% | 11 |
|
|
2023
Q1 | $14.1M | Buy |
58,335
+4,278
| +8% | +$1.05M | 1.24% | 12 |
|
|
2022
Q4 | $14.2M | Sell |
54,057
-209
| -0.4% | -$56K | 1.41% | 6 |
|
|
2022
Q3 | $12.2M | Sell |
54,266
-60
| -0.1% | -$14.5K | 1.38% | 9 |
|
|
2022
Q2 | $13.2M | Buy |
54,326
+300
| +0.6% | +$73.5K | 1.43% | 9 |
|
|
2022
Q1 | $13.1M | Buy |
54,026
+4,742
| +10% | +$1.09M | 1.14% | 12 |
|
|
2021
Q4 | $11.1M | Buy |
49,284
+2,012
| +4% | +$425K | 1.08% | 11 |
|
|
2021
Q3 | $10.1M | Buy |
47,272
+2,320
| +5% | +$534K | 1.45% | 9 |
|
|
2021
Q2 | $11M | Buy |
44,952
+2,344
| +6% | +$577K | 1.67% | 7 |
|
|
2021
Q1 | $10.6M | Buy |
42,608
+4,473
| +12% | +$1.07M | 1.79% | 7 |
|
|
2020
Q4 | $8.77M | Buy |
38,135
+33,765
| +773% | +$7.78M | 1.67% | 7 |
|
|
2020
Q3 | $1.11M | Sell |
4,370
-4,626
| -51% | -$1.15M | 0.28% | 95 |
|
|
2020
Q2 | $2.12M | Buy |
8,996
+253
| +3% | +$57.7K | 0.63% | 45 |
|
|
2020
Q1 | $1.77M | Buy |
8,743
+4,279
| +96% | +$935K | 0.73% | 31 |
|
|
2019
Q4 | $1.08M | Buy |
4,464
+2,211
| +98% | +$487K | 0.35% | 82 |
|
|
2019
Q3 | $436K | Sell |
2,253
-15
| -0.7% | -$2.88K | 0.18% | 113 |
|
|
2019
Q2 | $418K | Buy |
2,268
+813
| +56% | +$146K | 0.16% | 116 |
|
|
2019
Q1 | $276K | Buy |
+1,455
| New | +$278K | 0.11% | 141 |
|
Other funds holding AMGN
Ashton Thomas Private Wealth's AMGN Position: Q2 2026 in Review
Ashton Thomas Private Wealth increased its Amgen (AMGN) stake by 3.4% in Q2 2026, buying an estimated $1.18M and bringing the position to 103,640 shares worth $37.5M. The position accounts for 0.78% of the portfolio, ranked #19.
Ashton Thomas Private Wealth first reported a position in AMGN in Q1 2019 and has held it in 30 quarters since. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Ashton Thomas Private Wealth held 103,640 shares of Amgen worth $37.5M as of Q2 2026.
- Ashton Thomas Private Wealth bought 3,434 Amgen shares in Q2 2026, an estimated $1.18M.
- Amgen made up 0.78% of Ashton Thomas Private Wealth's portfolio in Q2 2026, its #19 holding.
- Ashton Thomas Private Wealth first reported a position in Amgen in Q1 2019 and has held it in 30 quarters since.
- 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Ashton Thomas Private Wealth's 13F filing for Q2 2026, filed 29 Jul 2026.